Home / Killer Apps Headlines / ENHERTU® Now Available in U.S. for HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based Regimens

ENHERTU® Now Available in U.S. for HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based Regimens

This post was originally published on link to source

TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo announces the availability of ENHERTU (fam-trastuzumab deruxtecan-nxki) in the U.S.

About kanmg

Check Also

Market Logic and Visa Win 2019 BIG Innovation Award

This post was originally published on link to sourceBERLIN, Jan. 22, 2020 /PRNewswire/ — Market …